The Menopause Clinic
Request

Treatment

Vaginal estrogen and local therapy

Vaginal estrogen is a low dose of estrogen placed directly in the vagina as a cream, tablet, insert, or ring. It restores the thickness, elasticity, and blood supply of vaginal and urethral tissue, and very little reaches the bloodstream. It is first-line treatment for genitourinary syndrome of menopause, and the AUA/CUA/SUFU recurrent UTI guideline recommends offering it to peri- and postmenopausal women with recurrent urinary tract infections to reduce future infections.

Who this is for

  • Women with vaginal dryness, burning, or pain with sex after menopause
  • Women with two or more urinary tract infections in six months, or three or more in a year, after menopause
  • Women with urinary urgency, frequency, or burning that is not explained by infection
  • Women already on systemic hormone therapy whose genitourinary symptoms have not fully resolved — the two are frequently used together
  • Women on aromatase inhibitors with severe genitourinary symptoms, as a shared decision with their oncologist

What it is and why it works

The tissue of the vagina, vulva, urethra, and bladder neck is loaded with estrogen receptors. When estrogen falls after menopause, that tissue thins, loses elasticity and blood supply, and the vaginal pH rises from around 4 toward 6 or 7. Protective lactobacilli decline and gut bacteria colonize more easily.

Low-dose vaginal estrogen reverses those changes locally. The epithelium thickens, blood flow improves, lubrication returns, pH falls, and lactobacilli recolonize. That last part is why the same treatment that fixes dryness also reduces urinary tract infections: it restores the barrier that was keeping E. coli out.

The dose is the point. These products deliver a small fraction of what systemic therapy delivers, and serum levels generally stay within the postmenopausal range — which is what makes it usable in women for whom systemic estrogen is off the table.

What to expect

Most products start with a loading phase — nightly for about two weeks — and then drop to twice a week for maintenance. The ring is the exception: you place it and replace it every 90 days.

Give it time. Some women notice a difference in two or three weeks, but the tissue takes about 12 weeks to fully respond. Judging it at four weeks is judging it too early.

Early on, some women notice mild irritation or discharge as the tissue changes. That usually settles. What is not expected is bleeding — if you bleed, tell us, and we will evaluate it rather than attribute it to the medication.

Where it fits in a bigger plan

For dryness and painful sex, vaginal estrogen plus a regular moisturizer plus a lubricant for sex covers most women. If painful sex has gone on long enough that your pelvic floor muscles have learned to guard, physical therapy is added, because tissue treatment alone will not undo a muscle pattern.

For recurrent UTIs, vaginal estrogen is the backbone of prevention. We often overlap it with a short course of antibiotic prophylaxis at first and then taper the antibiotic, because the estrogen takes weeks to work and you should not be left unprotected in the meantime.

For urgency, it is one layer. Bladder training, treating constipation, and sometimes medication go alongside it.

Options

Local options for genitourinary syndrome of menopause. All are FDA-approved; none are compounded.
Form How it is taken Typical use
Estradiol vaginal cream Applicator at bedtime, nightly for 2 weeks, then twice weeklyMost adjustable dose, and the cream itself can be applied to the vulva and vaginal opening where much of the pain lives.
Conjugated estrogens vaginal cream Applicator, cyclically or twice weeklyAn alternative cream, sometimes preferred based on formulary coverage.
Estradiol vaginal insert (tablet) A small insert, nightly for 2 weeks, then twice weeklyCleaner and less messy than cream. A common choice when the main symptom is internal rather than at the opening.
Estradiol vaginal ring A soft ring you place yourself, replaced every 90 daysBest option if you would rather not think about it. You cannot feel it, and it does not interfere with sex.
Prasterone (vaginal DHEA) A nightly insertA non-estrogen local option. Converted to estrogen and androgen inside the vaginal cells themselves.
Ospemifene An oral tablet once a dayA selective estrogen receptor modulator taken by mouth. Useful when nothing vaginal is acceptable. Not used in women with a history of breast cancer.

What the evidence supports

Each claim below carries a rating. Strong means randomized trials and current specialty guidelines support it. Moderate means the evidence is real but has meaningful limits. Limited means early, small, or indirect evidence — and where we say Limited, that is us telling you not to count on it.

  • Improves vaginal dryness and pain with sex

    Evidence for Improves vaginal dryness and pain with sex: Strong evidence

    Multiple randomized trials show improvement in symptoms and in the tissue itself across all the local estrogen forms. Effects appear by 4 to 8 weeks, with full benefit at about 12 weeks.

  • Reduces recurrent urinary tract infections after menopause

    Evidence for Reduces recurrent urinary tract infections after menopause: Strong evidence

    Randomized trials show significant reductions in recurrence, and the AUA/CUA/SUFU recurrent uncomplicated UTI guideline recommends clinicians offer vaginal estrogen to peri- and postmenopausal women with recurrent UTIs for this purpose.

  • Improves urinary urgency and frequency

    Evidence for Improves urinary urgency and frequency: Moderate evidence

    Trials and systematic reviews show benefit for urgency, frequency, and urge incontinence, though effect sizes vary. Often combined with bladder training or medication rather than used alone.

  • Very low systemic absorption at standard doses

    Evidence for Very low systemic absorption at standard doses: Strong evidence

    Serum estradiol on low-dose vaginal therapy generally stays in the postmenopausal range. This is the basis for using it in situations where systemic estrogen would not be appropriate.

  • Prevents fractures or treats hot flashes

    Evidence for Prevents fractures or treats hot flashes: Limited evidence

    It does not, and we do not prescribe it for either. Doses this low are not intended to produce whole-body effects. If you need bone protection or hot flash control, that is a separate conversation about systemic therapy.

What this treats

Common questions

Is this the same as hormone replacement therapy?

No. Systemic hormone therapy is designed to circulate through your body and treat whole-body symptoms. Vaginal estrogen is a much lower dose placed where the problem is, and blood levels generally stay in the postmenopausal range. They answer different questions and are often used together.

Do I need to take progesterone with it?

Generally no. At the low doses used for local therapy, endometrial stimulation is not expected, and routine progesterone is not recommended for women with a uterus on standard vaginal estrogen doses. Any vaginal bleeding changes that — it gets evaluated regardless of dose.

Does it still have a boxed warning?

In late 2025 the FDA removed the class-wide boxed warning from estrogen product labeling, including low-dose vaginal products. Many clinicians had argued for years that applying warnings derived from systemic therapy to a low-dose local product misled patients. Your individual history is still reviewed before prescribing.

How long do I have to use it?

Indefinitely, if it is working. Genitourinary syndrome of menopause is a progressive tissue change, not an episode. When women stop, symptoms usually return within a few months. Most women move to a twice-weekly maintenance dose and stay there.

I had breast cancer. Is this an option?

It may be. We start with non-hormonal moisturizers and lubricants. If those are not enough and symptoms are significantly affecting your life, low-dose vaginal estrogen is used in some survivors — a decision made together with your oncologist, and one that gets weighed differently for women on aromatase inhibitors than for those on tamoxifen or no endocrine therapy.

Which form should I pick?

Mostly personal preference and insurance coverage. Cream lets you treat the vulva and the vaginal opening directly, which matters when that is where the pain is. Inserts are tidier. The ring is the easiest to live with because you replace it four times a year and otherwise forget about it.

Medically reviewed by PLACEHOLDER — Medical Director, MD · Reviewed · Updated
PLACEHOLDER: replace with the reviewing clinician before launch.

Ready to talk to someone who treats this every day?

Insurance-based visits across metro Atlanta. No membership, no cash-pay program, no obligation to start hormones.

Request an appointment Call (770) 800-0000